Moreover, [68Ga]-IRDye800CW-BBN (Figure 9), a near-infrared fluorescence (NIRF) targeting GRPR in glioblastoma multiforme, had also entered clinical trials for further assessments. This evidence concerns the gene GRPR and glioblastoma.